Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: A genetic form of vascular dementia

Seminars in Cerebrovascular Diseases and Stroke

Volumn 4, Issue 2 SPEC. ISS., 2004, Pages 102-108

  Ruchoux, Marie Magdeleine ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

CADASIL; Notch3; Subcortical vascular dementia; Transgenic animal models; White matter disease

Indexed keywords

MEMBRANE RECEPTOR; NOTCH3 RECEPTOR;

AGE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN INJURY; BRAIN ISCHEMIA; CADASIL; CELL FATE; CHROMOSOME 19; CHROMOSOME ARM; CLINICAL FEATURE; DEATH; DEPRESSION; DISEASE MODEL; DISEASE SEVERITY; DROSOPHILA; GENE EXPRESSION; GENE MUTATION; HUMAN; MIGRAINE; MOUSE; MULTIINFARCT DEMENTIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RISK FACTOR; SEIZURE; SKIN BIOPSY; SMOOTH MUSCLE FIBER; STROKE; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE; WHITE MATTER;

EID: 16844376536     PISSN: 15289931     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.scds.2004.10.004     Document Type: Article

References (39)

1. L. van Bogaert Encéphalopathie sous-corticale progressive (Binswanger) à évolution rapide chez deux sæurs Méd Hellénique 24 1955 961-972
2. P. Sourander J. Wålinder Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease Acta Neuropathol (Berl) 39 1977 247-254
3. V. Sonninen M.L. Savontaus Hereditary multi-infarct dementia Eur Neurol 27 1987 209-215
4. D.L. Stevens R.H. Hewlett B. Brownell Chronic familial vascular encephalopathy Lancet I 1977 1364-1365
5. M.G. Bousser E. Tournier-Lasserve R. Aylward A. Tourbah D. Dormont N. Romero E. Cabanis M. Fardeau Recurrent strokes in a family with diffuse white-matter abnormalities - A new mitochondrial cytopathy? J Neurol 235 Suppl. 1 1988 S4-S5
6. M. Baudrimont F. Dubas A. Joutel E. Tournier-Lasserve M.G. Bousser Autosomal dominant leukoencephalopathy and subcortical ischemic strokes: A clinicopathological study Stroke 24 1993 122-125
7. E. Tournier-Lasserve A. Joutel J. Melki J. Weissenbach G.M. Lathrop H. Chabriat J.L. Mas E.A. Cabanis M. Baudrimont J. Maciazek M.A. Bach M.G. Bousser Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) maps to chromosome 19p12 Nat Genet 3 1993 256-259
8. M.M. Ruchoux D. Guerouaou B. Vandenhaute J.P. Pruvo P. Vermersch D. Leys Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Acta Neuropathol 89 1995 500-512
9. A. Joutel C. Corpechot A. Ducros K. Vahedi H. Chabriat P. Mouton S. Alamowitch V. Domenga M. Cecillion E. Marechal J. Maciazek C. Vayssiere C. Cruaud E.A. Cabanis M.M. Ruchoux J. Weissenbach J.F. Bach M.G. Bousser E. Tournier-Lasserve Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia Nature 383 1996 707-710
10. H. Chabriat K. Vahedi M.T. Iba-Zizen A. Joutel A. Nibbio T.G. Nagy M.O. Krebs J. Julien B. Dubois X. Ducroca M. Levasseur P. Homeyer J.L. Mas O. Lyon-Caen E. Tournier-Lasserve M.G. Bousser Clinical spectrum of CADASIL: A study of 7 families Lancet 346 1995 934-939
11. M. Dichgans M.M. Mayer I. Uttner R. Bruning J. Muller-Hocker G. Rungger M. Ebke T. Klockgether T. Gasser The phenotypic spectrum of CADASIL: Clinical findings in 102 cases Ann Neurol 44 1998 731-739
12. H. Kalimo M.M. Ruchoux M. Viitanen R.N. Kalaria CADASIL: A common form of hereditary arteriopathy causing brain infarcts and dementia Brain Pathol 12 2002 371-384
13. M. O'Sullivan J.M. Jarosz R.J. Martin N. Deasy J.F. Powell H.S. Markus MRI hyperintensities of temporal lobe and external capsule in patients with CADASIL Neurology 56 2001 628-634
14. H. Chabriat T. Mrissa C. Levy M.T. Iba-Zizen E. Tournier-Lasserve M.G. Bousser Brain stem MRI signal abnormalities in CADASIL Stroke 30 1999 457-459
15. H. Chabriat C. Levy H. Taillia Patterns of MRI lesions in CADASIL Neurology 51 1998 452-457
16. H. Chabriat S. Pappata C. Poupon C. Clarck K. Vahedi F. Poupon J. Mangin M. Pachot-Clouard A. Jobert D. Lebihan M.G. Bousser Clinical severity in CADASIL related to ultrastructural damage in white matter. In vivo study with diffusion tensor MRI Stroke 30 1999 2637-2643
17. M.M. Ruchoux C.A. Maurage CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy J Neuropathol Exp Neurol 56 1997 947-964
18. A. Joutel F. Andreuxs S. Gaulis V. Domanga M. Cecillion N. Battail N. Piga F. Chapon C. Godfraind E. Tournier-Lasserve The ectodomain of Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients J Clin Invest 105 2000 597-605
19. A. Joutel P. Favrole P. Labauge H. Chabriaat C. Lescoat F. Andreux V. Domenga M. Cecillon K. Vehedi A. Ducros F. Cave-Riant M.G. Bousser E. Tournier-Lasserve Skin biopsy immunostaining with Notch3 monoclonal antibody for CADASIL diagnosis Lancet 358 2001 2049-2051
20. S.A. Lesnick Oberstien S.G. Van Duinen R. van den Boom M.L. Maat-Schieman M.A. van Buchem H.C. van Houwelingen I.M. Hegeman-Kleinn M.D. Ferrari M.H. Breuning J. Haan Evaluation of diagnostic Notch3 immunostaining in CADASIL Acta Neuropathol (Berl) 106 2003 107-111
21. P. Brulin C. Godfraind E. Leteurtre M.M. Ruchoux Morphometric analysis of ultrastructural vascular changes in CADASIL: Analysis of 50 skin biopsy specimens and pathogenic implications Acta Neuropathol (Berl) 104 2002 241-248
22. S. Artanavis-Tsakonas M.D. Rand R.J. Lake Notch signalling; cell fate control and signal integration in development Science 284 1999 770-776
23. H. Karlsrom P. Beatus K. Daneus G. Chapman U. Lendahl J.K. Lundkvist A CADASIL-mutated Notch3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling Proc Natl Acad Sci USA 90 2002 506-508
24. A. Joutel K. Vahedi C. Corpechot A. Troesh H. Chabriat C. Vayssiere C. Cruaud J. Maciazek J. Weissenbach M.G. Bousser J.F. Bach E. Tournier-Lasserve Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients Lancet 350 1997 1511-1515
25. A. Joutel H. Chabriat K. Vahedi V. Domenga C. Vayssiere M.M. Ruchoux C. Lucas D. Leys M.G. Bousser E. Tournier-Lasserve Splice site mutation causing a 7 amino acid Notch3 in frame deletion in CADASIL Neurology 54 2000 1874-1875
26. S. Tuominen V. Juvonen K. Amberla T. Jolma J.O. Rinne S. Tuisku T. Kurtki R. Marttila M. Poyhonen M.L. Savontaus M. Viitanen H. Kalimo Phenotype of a homozygous CADASIL patient with the same R133C Notch3 mutation Stroke 32 2001 1767-1774
27. C. Haritoglou J.P. Hoops F.H. Stefani P. Mehraein A. Kampik M. Dichgans Histopathological abnormalities in ocular blood vessels of CADASIL patients Am J Ophthalmol 138 2004 302-305
28. A. Rufa M.T. Dotti P. Frezzotti N. De Stefano A. Caporossi A. Federico Hemodynamic evaluation of the optic nerve head in CADASIL Arch Neurol 61 2004 1230-1233
29. M. Liebetrau J. Herzog C.U. Kloss G.F. Hamann M. Dichgans Prolonged cerebral transit time in CADASIL: A transcranial ultrasound study Stroke 33 2002 509-512
30. 2 reactivity in CADASIL: A transcranial Doppler sonographic study Stroke 32 2001 17-21
31. A. Joutel D.D. Dodick J.E. Parisi M. Cecillon E. Tournier-Lasserve M.G. Bousser De novo mutation in the Notch3 gene causing CADASIL Ann Neurol 47 2000 388-391
32. K.J. Fryxell M. Soderlund T.V. Jordan An animal model for the molecular genetics of CADASIL Stroke 32 2001 6-11
33. A. Joutel M. Monet V. Domenga F. Riant E. Tournier-Lasserve Pathogenic mutations associated with CADASIL differently affect Jagged1 binding and Noth3 activity via the RBP/JK signalling pathway Am J Hum Genet 74 2004 338-347
34. M.M. Ruchoux V. Domenga P. Brulin J. Maciazek S. Limol E. Tournier-Lasserve A. Joutel Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Am J Pathol 162 2003 329-342
35. H. Chabriat S. Pappata L. Ostergaard C.A. Clark M. Pachot-Clouard K. Vahedi A. Jobert D. Le Bihan M.G. Bousser Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking Stroke 31 2000 1904-1912
36. N. Molko S. Pappata J.F. Mangin C. Poupon K. Vahedi M. Pachot-Clouard A. Jobert D. Le Bihan M.G. Bousser H. Chabriat Diffusion tensor imaging study in subcortical gray matter Stroke 32 2001 2049-2054
37. D.P. Auer T. Schirmer J.O. Heidenreich J. Herzog B. Putz M. Dichgans Altered white and gray matter metabolism in CADASIL: A proton MR spectroscopy and 1H-MRSI study Neurology 56 2001 635-642
38. H. Yonekura S. Sakurai X. Liu H.K. Migita H. Wang S.I. Yamagishi M. Nomura J. Abedin H. Unoki Y. Yamamoto Y. Hiroshi Y. Yamamoto Placenta growth factor and vascular endothelial growth factor B and C. Expression in microvascular endothelial cells and pericytes J Biol Chem 274 1999 35172-35178
39. M.M. Ruchoux P. Brulin J. Brillault M.P. Dehouck R. Cecchelli M. Bataillard Lessons from CADASIL Ann NY Acad Sci 977 2002 224-231